Stock Research for SGMO

SGMO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SGMO Stock Chart & Research Data

The SGMO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGMO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SGMO Due diligence Resources & Stock Charts

The SGMO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SGMO Detailed Price Forecast - CNN Money CNN View SGMO Detailed Summary - Google Finance
Yahoo View SGMO Detailed Summary - Yahoo! Finance Zacks View SGMO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SGMO Trends & Analysis - Trade-Ideas Barrons View SGMO Major Holders - Barrons
NASDAQ View SGMO Call Transcripts - NASDAQ Seeking View SGMO Breaking News & Analysis - Seeking Alpha
Spotlight View SGMO Annual Report - CompanySpotlight.com OTC Report View SGMO OTC Short Report - OTCShortReport.com
TradeKing View SGMO Fundamentals - TradeKing Charts View SGMO SEC Filings - Bar Chart
WSJ View Historical Prices for SGMO - The WSJ Morningstar View Performance/Total Return for SGMO - Morningstar
MarketWatch View the Analyst Estimates for SGMO - MarketWatch CNBC View the Earnings History for SGMO - CNBC
StockMarketWatch View the SGMO Earnings - StockMarketWatch MacroAxis View SGMO Buy or Sell Recommendations - MacroAxis
Bullish View the SGMO Bullish Patterns - American Bulls Short Pains View SGMO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SGMO Stock Mentions - StockTwits PennyStocks View SGMO Stock Mentions - PennyStockTweets
Twitter View SGMO Stock Mentions - Twitter Invest Hub View SGMO Investment Forum News - Investor Hub
Yahoo View SGMO Stock Mentions - Yahoo! Message Board Seeking Alpha View SGMO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SGMO - SECform4.com Insider Cow View Insider Transactions for SGMO - Insider Cow
CNBC View SGMO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SGMO - OTC Markets
Yahoo View Insider Transactions for SGMO - Yahoo! Finance NASDAQ View Institutional Holdings for SGMO - NASDAQ


Stock Charts

FinViz View SGMO Stock Insight & Charts - FinViz.com StockCharts View SGMO Investment Charts - StockCharts.com
BarChart View SGMO Stock Overview & Charts - BarChart Trading View View SGMO User Generated Charts - Trading View




Latest Financial News for SGMO


Is Sangamo Therapeutics Inc. a Buy?
Posted on Thursday October 18, 2018

Can this beaten-down gene-editing and gene therapy biotech bounce back?


Analysis: Positioning to Benefit within New York, KB Home, Sangamo Therapeutics, INTL FCStone, Maiden, and MobileIron — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Wednesday October 17, 2018

NEW YORK, Oct. 17, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.


Taking Stock of Gilead’s Operational Performance
Posted on Monday October 08, 2018

Gilead Sciences’ (GILD) selling, general, and administrative expenses increased from $897.0 million in the second quarter of 2017 to $980.0 million in the second quarter. The increase was due to higher stock-based compensation expenses and costs after the Kite acquisition.


Sangamo Therapeutics Stock Is in Bearish Territory
Posted on Friday October 05, 2018

On October 4, Sangamo Therapeutics (SGMO) stock ended the trading day at $14.81—down ~3.4% from the previous day’s close. The stock registered its 52-week high of $27.50 on February 22. Sangamo Therapeutics reported its 52-week low of $11.30 on October 26, 2017. Currently, the stock is trading ~5.5% lower than its 50-day moving average of $15.68 and ~9% lower than its 200-day moving average of $16.27.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.